Johnson & Johnson (NYSE:JNJ) is back at it, making moves that have everyone in the MedTech world raising an eyebrow. This time, the healthcare giant is looking to offload its stroke care business, Cerenovus, for a cool $1 billion to $1.5 billion....
Join 250,000+
professionals today
Add Insights to your inbox - get the latest
professional news for free.
Johnson & Johnson to Sell Cerenovus Stroke Unit for $1B+
Join our 250K+ subscribers
Join our 250K+ subscribers
Subscribe13 FEB 2025 / BUSINESS
Healthcare giant Johnson & Johnson plans to sell its stroke care business Cerenovus for between $1 and $1.5 billion as part of its strategy to focus on profitable MedTech sectors, including cardiovascular technology and neuroscience. The decision comes as part of the company's restructuring, which has been triggered by declining COVID-19 treatment sales and includes spending $30 billion on acquiring top MedTech firms and a potential $8 billion settlement in talcum powder lawsuits.
Johnson & Johnson (NYSE:JNJ) is back at it, making moves that have everyone in the MedTech world raising an eyebrow. This time, the healthcare giant is looking to offload its stroke care business, Cerenovus, for a cool $1 billion to $1.5 billion....
Until next time…
Don’t forget to share this story on LinkedIn, X and Facebook
Subscribe now for $199 and get unlimited access to MYCPE ONE, from CPE credits to insights Magazine
📢MYCPE ONE Insights has a newsletter on LinkedIn as well! If you want the sharpest analysis of all accounting and finance news without the jargon, Insights is the place to be! Click Here to Join
Transforming Finance & Accounting Operations for Enterprises with MYCPE ONE
We proudly serve 100+ clients, helping them streamline and transform their finance & accounting operations. Our comprehensive suite of F&A outsourcing services is available under one umbrella, that eliminates the need for in-house F & A Operations By partnering with us, you gain access to:
Our Full-Suite F&A Services Include:
We work closely with CPA and accounting firms to help their end clients transform their F&A operations, and partner with them in delivering real business value.
Feel free to schedule a no-obligation discovery call
You’ve reached the 3 free-content piece limit. Unlock unlimited access to all News & CPE resources.
Subscribe Today.
Already have an account?
Sign In
